Manager Regulatory Consumer Research Stamford CT, USA Consumer

Be a part of a revolutionary change

At PMI, we’ve chosen to do something incredible. We’re totally transforming our business and building our future on one clear purpose – to deliver a smoke-free future.

With huge change, comes huge opportunity. So, wherever you join us, you’ll enjoy the freedom to dream up and deliver better, brighter solutions and the space to move your career forward in endlessly different directions.

Our success depends on people who are committed to our purpose and have an appetite for progress.

We are excited that our US headquarters in NYC has moved to Stamford, Connecticut as of November 2022. Our beautiful new location is just steps away from the Stamford Metro-North Train Station and easily accessible from NYC.

The Manager of Regulatory and Consumer Research has three main purposes: 1) lead the design, development, implementation, analysis, and reporting of post-market studies by applying existing or innovative scientifically robust theories and practices; 2) contribute to the narrative writing of submissions to the FDA; and 3) analyze, model, interpret, present, and disseminate results to internal and external audiences.

Your ‘day to day’:

• Manage post-marketing complex research in the U.S. and potentially Rest of the World (RoW), including design, execution and interpretation of results, in order to fulfil regulatory requirements (e.g., U.S. FDA) and to provide data on the effect of smoke-free products on the whole population.

• Manage the preparation of consumer related regulatory submissions (mostly in the U.S.) input on the post-market sections in order to obtain the ability to commercialize smoke-free products.

• Contribute to PMI’s scientific visibility, communication, and influence by developing and publishing of scientific manuscripts in recognized external journals as well as of oral or poster presentations for scientific conferences.

• Analyze, interpret, present and disseminate post-market study results verbally and in writing, in order to maximize internal knowledge and alignment.

• Directly interact with key internal stakeholders including Regulatory Affairs, External Affairs, Scientific Engagement and Consumer Insights.

Who we’re looking for:

• Bachelor’s Degree and a minimum of 5 years of applying scientific and epidemiological practices, procedures and theory related to pre- and post-market studies, within a pharmaceutical, tobacco, consumer goods, clinical research, or governmental agency environment.
• Technical expertise in design, development, and implementation of pre- and post-market studies in social science, health services, epidemiology, pharmaceutical or tobacco.
• Specific Experience: Strong statistical and analytical skills as well as in using specialized statistical software (e.g., SPSS, SAS).

• Confirmed leadership skills, results-oriented and ability to work in a collaborative set-up. Sound oral and written communications skills, ability to summarize and disseminate analyses. Fluent in English, both written and spoken.

• Legally authorized to work in the U.S.

Annual Base Salary Range: $144,000-$198,000

What we offer

• We offer a competitive base salary, annual bonus (applicable based on level of position), great medical, dental and vision coverage, 401k with a generous company match, incredible wellness benefits, commuter benefits, pet insurance, generous PTO, and much more!
• We have implemented Smart Work, a hybrid model of working that promotes flexibility in the workplace.
• Seize the freedom to define your future and ours. We’ll empower you to take risks, experiment and explore.
• Be part of an inclusive, diverse culture where everyone’s contribution is respected; Collaborate with some of the world’s best people and feel like you belong.
• Pursue your ambitions and develop your skills with a global business – our staggering size and scale provides endless opportunities to progress.
• Take pride in delivering our promise to society: To improve the lives of a billion smokers.

#LI-Hybrid

PMI is an Equal Opportunity Employer


PMI Global Services Inc. and PM Global Brands Inc. are a subsidiary of Philip Morris International Inc. Philip Morris International (PMI) is leading a transformation in the tobacco industry to create a smoke-free future and ultimately replace cigarettes with smoke-free products to the benefit of adults who would otherwise continue to smoke, society, the company, its shareholders and its other stakeholders. PMI is a leading international tobacco company engaged in the manufacture and sale of cigarettes, as well as smoke-free products, associated electronic devices and accessories, and other nicotine-containing products in markets outside the U.S. In addition, PMI ships versions of its IQOS Platform 1 device and consumables to Altria Group, Inc. for sale under license in the U.S., where these products have received marketing authorizations from the U.S. Food and Drug Administration (FDA) under the premarket tobacco product application (PMTA) pathway; the FDA has also authorized the marketing of a version of IQOS and its consumables as a Modified Risk Tobacco Product (MRTP), finding that an exposure modification order for these products is appropriate to promote the public health. PMI is building a future on a new category of smoke-free products that, while not risk-free, are a much better choice than continuing to smoke. Through multidisciplinary capabilities in product development, state-of-the-art facilities and scientific substantiation, PMI aims to ensure that its smoke-free products meet adult consumer preferences and rigorous regulatory requirements. PMI's smoke-free product portfolio includes heat-not-burn and nicotine-containing vapor products. As of September 30, 2022, PMI's smoke-free products are available for sale in 70 markets in key cities or nationwide, and PMI estimates that approximately 13.5 million adults around the world, excluding Russia and Ukraine have already switched to IQOS and stopped smoking. For more information, please visit www.pmi.com and www.pmiscience.com.
Philip Morris International is committed to a safe workplace. We have implemented COVID-19 safety protocols that meet or exceed local public health guidelines. Workplace safety remains our number one priority. As a result, PMI recommends all US- and Canada-based employees to be vaccinated in order to access any of our facilities; this is subject to change solely at the Company’s discretion.